Identifying Improvements in an ED Elder Friendly Area Based on Patient Experience (EDEFA_TheirVoice Project) (TheirVoice)

Identifying Improvements in an Emergency Department Elder Friendly Area Based on Patient Experience (EDEFA_TheirVoice Project)

Analyze patient experience of elders admitted to the Emergency Department Elder Friendly Area (EFA) and determine possible improvement options and potential solutions.

The project will use a creative problem-solving methodology (Design Thinking) to analyze the care process based on the experience of Elder Friendly Area (EFA) users and their families

Study Overview

Status

Unknown

Conditions

Detailed Description

Method: This is a qualitative and quantitative evaluation project. The project will use a creative problem-solving methodology (Design Thinking) to analyze the care process based on the experience of Elder Friendly Area (EFA) users and their families. Design Thinking is a creativity and innovation methodology that compiles tools based on design principles for problem solving. It is characterized by having the ability to mix convergent and divergent thinking, reconciling rational and intuitive thinking. This methodology consists of 4 phases: Mapping, Exploring, Building and Testing. In each of them, the tools and techniques help us to observe, get involved and immerse ourselves in the patient's ecosystem, with the aim of designing a solution WITH the user and not just FOR him. Consequently, the error is reduced and the modifications and improvements of our projects are speeded up.

Patients: Patients/caregivers attended in the Emergency Department's EFA will participate . In the first fieldwork, 50-60 patients will participate, conducting a self-completed interview (prior informed consent, 10 minutes long).

In the qualitative research phase, 5-10 patients/caregivers conduct a 30-minute interview with the Design Thinking professional. The co-creation workshop lasts a couple of hours and 5 to 10 patients/caregivers will participate. In the second fieldwork another 50-60 patients will participate. In total, between 110 and 140 patients will be enrolled.

Ethics: Patients/caregivers will be provided with a patient information sheet and informed consent prior to participation. Patient experience data will be collected by Design Thinking professional on an anonymous basis and will always be handled on an aggregate basis.

Funding: The project will be developed in collaboration with Merck Sharp & Dohme Spain, with which there is an agreement signed (Fundació de Gestió HSCSP - MSD). For the correct development of it, MSD has hired a company expert in the development of this type of dynamics (Thinkers&Co) which will participate actively in all meetings and workshops and will be responsible for collecting the opinion of the patient anonymously and manage this information in an aggregate way, always with the intention of identifying the points of improvement on which later health professionals will work with the methodology described. However, no monetary payment will be made to the hospital, to the emergency department or to the professionals involved. The collaboration of MSD and Thinkers&Co will not affect the independent nature of the project.

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Mireia Puig

Study Locations

      • Barcelona, Spain, 08025
        • Recruiting
        • Hospital de la Santa Creu I Sant Pau
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 110 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients attended in elder friendly area who agree to participate and their caregivers. All them are old frail people.

Description

Inclusion Criteria:

  • All patients attended in elder friendly area who agree to participate and their caregivers

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
First evaluation group (survey_1)
Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA)
Co-creation group
Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA) who want to participate in the co-creation workshop
Interventions will be those obtained from the co-creation workshop with patients
Second evaluation group (survey_2)
Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA), after improvements are made
Interventions will be those obtained from the co-creation workshop with patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quantitative improvement in the satisfaction survey
Time Frame: 1 month
A quantitative increase in the satisfaction survey obtained after the improvement implemented after the co-creation workshop.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Mireia Puig, Hospital de la Santa Creu i Sant Pau, Emergency Department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2018

Primary Completion (Anticipated)

November 22, 2018

Study Completion (Anticipated)

October 1, 2019

Study Registration Dates

First Submitted

October 22, 2018

First Submitted That Met QC Criteria

October 22, 2018

First Posted (Actual)

October 24, 2018

Study Record Updates

Last Update Posted (Actual)

October 24, 2018

Last Update Submitted That Met QC Criteria

October 22, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IIBSP-EXP-2018-80

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergencies

Clinical Trials on Procedure created in co-creation group

3
Subscribe